secwatch / observer
8-K filed June 4, 2026, 4:31 PM ET ticker COCO CIK 0001482981
other confidence high sentiment neutral materiality 0.15

Vita Coco stockholders elect three Class II directors, ratify auditor, approve say-on-pay

Vita Coco Company, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Vita Coco Company, Inc. shareholders approved Advisory vote on executive compensation. at the 2026-06-03 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-06-03
Exact text from the filing
Item 3 – Advisory vote on executive compensation.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Vita Coco Company, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-03 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-03
Exact text from the filing
Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Vita Coco Company, Inc. shareholders approved Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders in 2029. at the 2026-06-03 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-06-03
Exact text from the filing
On June 3, 2026, The Vita Coco Company, Inc. (the “Company”) held its Annual Meeting of Stockholders.
View on SEC.gov

1593 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Vita Coco Company, Inc. filing history →

Source: SEC EDGAR
accession 0001482981-26-000140
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.